Location: Home
  • search
  • go
  • Relate News
  • 6/14/2019Beigene Touts 'Encouraging' Response Rates as It Mounts Challenge To B...
  • 6/14/2019NMPA Restores Import of Fabrik Evers' HITRECHOL
  • 6/13/2019AstraZeneca Markets an Herbal-Based Remedy to Expand in China
  • 6/13/2019111 Enters Strategic Partnership Deal with Tong Ren Tang Tech to Advan...
  • 6/13/2019SEC probes Siemens, GE, Philips in alleged China medical equipment sch...
  • 6/13/2019Athenex and PharmaEssentia Announce Positive Early Clinical Signals of...
  • 6/13/2019Chinese Biopharma Firm Epimab Bags $74m Series B
  • 6/13/2019Parexel Teams with CLARINESS to Enhance Patient Access and Engagement ...
  • 6/13/2019BeiGene CEO John Oyler Elected to BIO Board of Directors
  • 6/13/2019US Senators Questions HHS Money and Chinese Genomics Firms
  • 6/13/2019China Launches Nasdaq-style Tech Board in Shanghai, Expects challenges
  • 6/13/2019China Approves First Human Trials of 4-Way Norovirus Vaccine
  • 6/13/2019Guangdong Highsun's Swine Fever Vaccine Met with Skepticism
  • 6/13/2019R2 Dermatology Signs Exclusive Asia-Pacific Distribution Agreement wit...
  • 6/13/2019Athenex Voluntarily Suspends Production at Its Chongqing API Plant
  • 6/13/2019Tessa Launches China JV in $120M Deal
  • 6/13/2019The U.S. Is Purging Chinese Cancer Researchers From Top Institutions
  • 6/13/2019Analyst Predicts Delay in Medytox's Obtaining Beijing's Nod for Botuli...
  • 6/13/2019Zai Lab Approved to Commercialize ZEJULA (Niraparib) in Macau for Rela...
  • 6/13/2019Terns Pharma Initiates a Phase 1 Clinical Trial of TERN-101
  • 6/13/2019In Depth: Why China's Drug-Review Revamp Is Stalling
  • 6/13/2019Tonix Pharma Granted Chinese Patent for the Composition and Formulatio...
  • 6/13/2019IBT: China Can Weaponize Prescription Drugs to Hit US in Trade War, Sa...
  • 6/13/2019China's Churning Out Revolutionary Cancer Drugs Much Cheaper Than the ...
  • 6/13/2019Hansoh Pharma Founder Becomes the Latest Chinese Pharma Billionaire
  • 6/13/2019NMPA Publishes List of Reference Formulations for Generic Drug Equival...
  • 6/13/2019NMPA Withdraws Approvals of 15 Drugs Including Five Import Drugs
  • 6/13/2019Gilead’s NDA for Vosevi Accpeted by the NMPA
  • 6/12/2019China Issues Notice on Promoting Healthy Development of Social Capital...
  • 6/12/2019CDE Issues Notice on Strengthened Certification Checks in Drug Marketi...
  • Page:278/775 Total number of articles:23233: [First][<<] [276] [277] [278] [279] [280] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group